According to the FDA, breakthrough therapy designation applies to a drug that “treats a serious or everyday living-threatening issue and preliminary scientific proof signifies that the drug might display sizeable improvements over readily available therapy with a clinically important endpoint.”Amid that surge in acceptance, The Times described